Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage

Zhang L, Dopfer-Jablonka A, Nehlmeier I, Kempf A, Graichen L, Calderón Hampel N, Cossmann A, Stankov MV, Morillas Ramos G, Schulz S, Jäck HM, Behrens GM, Pöhlmann S, Hoffmann M (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Vaccines MDPI

Book Volume: 12

Article Number: 487

Journal Issue: 5

DOI: 10.3390/vaccines12050487

Abstract

Transmissibility and immune evasion of the recently emerged, highly mutated SARS-CoV-2 BA.2.87.1 are unknown. Here, we report that BA.2.87.1 efficiently enters human cells but is more sensitive to antibody-mediated neutralization than the currently dominating JN.1 variant. Acquisition of adaptive mutations might thus be needed for efficient spread in the population.

Authors with CRIS profile

Sebastian Schulz Professur für Immunologie Hans-Martin Jäck Department of Molecular Immunology

Additional Organisation(s)

FAU Profilzentrum Licht.Materie.Quantentechnologien (FAU LMQ)

Involved external institutions

Deutsches Primatenzentrum (DPZ), Leibniz-Institut für Primatenforschung DE Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE)

How to cite

APA:

Zhang, L., Dopfer-Jablonka, A., Nehlmeier, I., Kempf, A., Graichen, L., Calderón Hampel, N.,... Hoffmann, M. (2024). Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage. Vaccines, 12(5). https://doi.org/10.3390/vaccines12050487

MLA:

Zhang, Lu, et al. "Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage." Vaccines 12.5 (2024).

BibTeX: Download